Important Safety Information - NAD+
What is this?
This Important Safety Information summarizes the most important warnings and precautions for NAD+, a compounded prescription medication that your provider has prescribed to support your wellness goals, if deemed clinically appropriate. It does not contain all possible information. You will also receive a medication guide or patient drug information sheet with your medication when it arrives from the pharmacy which contains full information about NAD+. You should read all of the information that comes with your prescription before taking your medication and at each refill. It’s important to take your medication as prescribed by your provider and to always read your prescription label and follow your healthcare provider's instructions.
NAD+ is compounded by licensed pharmacists and contains the active ingredient NAD+. Unless otherwise indicated, the safety information below is based on the known safety profiles of these active ingredients as used in the compounded medication.
Like all compounded medications, NAD+ is not FDA approved. This means that the safety, effectiveness, and quality of this medication has not been verified by the FDA, as the FDA does not verify the safety, effectiveness, and quality of any compounded drugs.
Who Should NOT Take NAD+
Do not take this medication if you:
Are allergic to NAD+, niacin, or niacinamide
Are already taking NAD+ in any other oral or injectable form
Are pregnant, think you may be pregnant, or are planning to get pregnant
Are breastfeeding, or plan to breastfeed.
Have active cancer, or have had cancer in the past
Have end-stage kidney disease and are on dialysis, or have chronic kidney disease (CKD) stage 4 or 5
Have had a stroke, mini-stroke, or transient ischemic attack (TIA) and have not been evaluated by a provider since your diagnosis, or are not following your post-stroke care plan
Had a solid-organ or stem-cell transplant less than 3 months ago, or have a transplant that is not working well
Have new or worsening chest pain, including at rest
Have an irregular or racing heartbeat with symptoms
Have unexplained fainting that is still being evaluated by a doctor
Have a history of heart attack, stent, or bypass and have not been evaluated by a cardiologist or primary care provider in the last 6 months, or are not following treatment recommendations
Have uncontrolled high blood pressure (top number of 170 or higher, or bottom number of 100 or higher)
Have diabetes with a hemoglobin A1C of 8% or higher
Before you take NAD+, tell your healthcare provider if you:
Have an autoimmune disease
Have other cardiovascular (heart or blood vessel) disease
Take blood thinners
Take insulin or a medicine that makes your body release more insulin
Are taking or plan to start testosterone or enclomiphene therapy (testosterone cypionate, Kyzatrex, enclomiphene, or enclomiphene with tadalafil). Start dates should be at least 10 days apart
Are taking or plan to start an oral GLP-1 medicine (Ozempic, Wegovy, or Foundayo pill). Start dates should be at least 10 days apart
Are taking or plan to start an injectable GLP-1 medicine (compounded semaglutide, Mounjaro, Zepbound, or generic liraglutide). Start dates should be at least 10 days apart
Are taking or plan to start an oral weight loss medication kit (bupropion, metformin, or naltrexone/topiramate/B12). Start dates should be at least 10 days apart
Have kidney disease, including chronic kidney disease (CKD) of unknown or unconfirmed stage
Have liver disease, including cirrhosis or severe liver problems
Have a history of high blood pressure and have not had a blood pressure reading in the past 6 months. Treatment may be held until a new reading below 170/100 is obtained
Have diabetes and have not had your A1C checked in the past 6 months. Treatment may be held until a new A1C result below 8% is obtained
Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and supplements.
Possible Side Effects
NAD+ may cause:
Common:
Injection-site pain, redness, or swelling
Nausea or vomiting
Unusual fatigue
Headache or dizziness
Chills or shaking
Flushing (a sudden feeling of warmth or heat, often with redness of the face).
Upset stomach
Muscle aches
Serious (seek medical care immediately):
Facial swelling
Shortness of breath
Chest pressure
Fainting
Rash
Hives
Missed Dose
If you miss a dose, skip it and take your next dose on your regular schedule. Do not take extra medicine to make up for a missed dose. Keep your planned on and off schedule.
Overdose
In case of overdose, seek medical attention immediately or contact Poison Control at 1-800-222-1222.
Storage
Store refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze. Protect from light. Note the date you first use the vial and discard 28 days after first use, even if medication remains.
Keep this medication and all needles and syringes out of the reach of children.
Medication Disposal
Place used needles, syringes, and empty or expired vials in an FDA-cleared sharps disposal container (or a puncture-resistant, tightly lidded heavy-duty plastic container). Do not place loose needles in household trash, and do not flush medication or pour it down a drain. For unused or expired medication, use a drug take-back site. See FDA – Safely Using Sharps and FDA – Disposal of Unused Medicines.
Telemedicine Disclosure: This prescription was issued via telemedicine. If you experience any concerning symptoms, contact your prescribing clinician or seek emergency care.
Disclaimer: This summary does not include all information about NAD+. For more details, speak with your healthcare provider or pharmacist. This information is intended to support, not replace, discussions with your healthcare provider.